DK2707480T3 - Viruslignende partikler og fremgangsmåde til fremstilling heraf - Google Patents
Viruslignende partikler og fremgangsmåde til fremstilling herafInfo
- Publication number
- DK2707480T3 DK2707480T3 DK12785518.7T DK12785518T DK2707480T3 DK 2707480 T3 DK2707480 T3 DK 2707480T3 DK 12785518 T DK12785518 T DK 12785518T DK 2707480 T3 DK2707480 T3 DK 2707480T3
- Authority
- DK
- Denmark
- Prior art keywords
- virus
- preparing
- particles
- procedure
- Prior art date
Links
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26041—Use of virus, viral particle or viral elements as a vector
- C12N2770/26042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161485955P | 2011-05-13 | 2011-05-13 | |
| PCT/CA2012/050279 WO2012155262A1 (en) | 2011-05-13 | 2012-05-01 | Virus-like particles and process for preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2707480T3 true DK2707480T3 (da) | 2017-11-13 |
Family
ID=47176093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12785518.7T DK2707480T3 (da) | 2011-05-13 | 2012-05-01 | Viruslignende partikler og fremgangsmåde til fremstilling heraf |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9833504B2 (enExample) |
| EP (2) | EP2707027A4 (enExample) |
| JP (2) | JP6213461B2 (enExample) |
| CN (2) | CN103648528A (enExample) |
| AU (1) | AU2012255595A1 (enExample) |
| BR (2) | BR112013029143A2 (enExample) |
| CA (2) | CA2835967A1 (enExample) |
| DK (1) | DK2707480T3 (enExample) |
| MX (1) | MX2013013228A (enExample) |
| NO (1) | NO2800866T3 (enExample) |
| WO (2) | WO2012155262A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103648528A (zh) | 2011-05-13 | 2014-03-19 | 弗利亚生物技术公司 | 番木瓜花叶病毒组合物及其用于刺激先天免疫应答的用途 |
| CA2924819A1 (en) * | 2013-09-19 | 2015-03-26 | Folia Biotech Inc. | Papaya mosaic virus and virus-like particles in cancer therapy |
| US10098936B2 (en) | 2014-04-02 | 2018-10-16 | Case Western Reserve University | Vaccination using plant virus particles linked to HER2 antigens |
| US11998594B2 (en) | 2014-04-02 | 2024-06-04 | Case Western Reserve University | Anti-cancer plant virus particles linked to HER2 antigens |
| JP2017528137A (ja) * | 2014-09-11 | 2017-09-28 | カディラ ヘルスケア リミティド | 卓越した免疫学的特性を有する卓越したヒトパピローマウイルス抗原及びそれを含むワクチン |
| WO2016127262A1 (en) * | 2015-02-12 | 2016-08-18 | Folia Biotech Inc. | Multimerized orthomyxovirus nucleoprotein and uses thereof |
| GB201708709D0 (en) | 2017-06-01 | 2017-07-19 | Univ York | Virus like particle |
| MX385484B (es) * | 2017-06-28 | 2025-03-14 | Univ Mexico Nac Autonoma | Vlps derivadas de virus de planta con dsrna encapsidado y metodo de sintesis. |
| FR3106648B1 (fr) * | 2020-01-28 | 2022-05-27 | Arkema France | Structure multicouche pour le transport ou le stockage de l’hydrogene |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443969A (en) * | 1992-10-29 | 1995-08-22 | Rutgers University | RNA packaging system |
| WO2004004761A2 (en) | 2002-07-05 | 2004-01-15 | Denis Leclerc | Adjuvant viral particle |
| US8101189B2 (en) * | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
| KR20060031607A (ko) | 2003-07-10 | 2006-04-12 | 사이토스 바이오테크놀로지 아게 | 패킹된 바이러스-양 입자 |
| WO2005042017A1 (en) | 2003-10-22 | 2005-05-12 | Id Biomedical Corporation Of Quebec | Compositions and methods for activating innate and allergic immunity |
| WO2008058369A1 (en) | 2006-11-15 | 2008-05-22 | Folia Biotech Inc. | Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| WO2008058396A1 (en) * | 2006-11-15 | 2008-05-22 | Folia Biotech Inc. | Papaya mosaic virus-based vaccines for influenza |
| US7799281B2 (en) | 2007-01-16 | 2010-09-21 | Festo Corporation | Flux concentrator for biomagnetic particle transfer device |
| EP2082042A4 (en) | 2007-01-26 | 2010-08-18 | Folia Biotech Inc | VACCINE VACCINE FROM PAPAYA MOSAIC AGAINST SALMONELLA TYPHI AND OTHER ENTEROBACTERIAL PATHOGENS |
| CA2742288A1 (en) | 2008-07-30 | 2010-02-04 | Folia Biotech Inc. | Multivalent vaccines based on papaya mosaic virus and uses thereof |
| WO2010030790A2 (en) | 2008-09-10 | 2010-03-18 | The Texas A&M University System | Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| CN103648528A (zh) | 2011-05-13 | 2014-03-19 | 弗利亚生物技术公司 | 番木瓜花叶病毒组合物及其用于刺激先天免疫应答的用途 |
-
2012
- 2012-05-01 CN CN201280023824.XA patent/CN103648528A/zh active Pending
- 2012-05-01 AU AU2012255595A patent/AU2012255595A1/en not_active Abandoned
- 2012-05-01 EP EP12786315.7A patent/EP2707027A4/en not_active Withdrawn
- 2012-05-01 BR BR112013029143A patent/BR112013029143A2/pt not_active IP Right Cessation
- 2012-05-01 CN CN201280022947.1A patent/CN103687942A/zh active Pending
- 2012-05-01 DK DK12785518.7T patent/DK2707480T3/da active
- 2012-05-01 JP JP2014509577A patent/JP6213461B2/ja not_active Expired - Fee Related
- 2012-05-01 WO PCT/CA2012/050279 patent/WO2012155262A1/en not_active Ceased
- 2012-05-01 BR BR112013029144A patent/BR112013029144A2/pt not_active IP Right Cessation
- 2012-05-01 CA CA2835967A patent/CA2835967A1/en not_active Abandoned
- 2012-05-01 MX MX2013013228A patent/MX2013013228A/es not_active Application Discontinuation
- 2012-05-01 WO PCT/CA2012/050278 patent/WO2012155261A1/en not_active Ceased
- 2012-05-01 EP EP12785518.7A patent/EP2707480B1/en not_active Not-in-force
- 2012-05-01 US US14/117,365 patent/US9833504B2/en active Active
- 2012-05-01 JP JP2014509576A patent/JP6093926B2/ja not_active Expired - Fee Related
- 2012-05-01 CA CA2835972A patent/CA2835972A1/en not_active Abandoned
- 2012-05-01 US US14/117,363 patent/US20140154288A1/en not_active Abandoned
-
2013
- 2013-01-04 NO NO13700794A patent/NO2800866T3/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2707027A4 (en) | 2015-06-03 |
| JP6213461B2 (ja) | 2017-10-18 |
| CN103648528A (zh) | 2014-03-19 |
| WO2012155262A1 (en) | 2012-11-22 |
| JP6093926B2 (ja) | 2017-03-15 |
| BR112013029143A2 (pt) | 2017-07-11 |
| US20140154288A1 (en) | 2014-06-05 |
| CA2835972A1 (en) | 2012-11-22 |
| US20140255439A1 (en) | 2014-09-11 |
| MX2013013228A (es) | 2013-12-12 |
| JP2014514350A (ja) | 2014-06-19 |
| AU2012255595A1 (en) | 2013-12-12 |
| EP2707480B1 (en) | 2017-08-02 |
| BR112013029144A2 (pt) | 2017-07-11 |
| EP2707480A1 (en) | 2014-03-19 |
| CA2835967A1 (en) | 2012-11-22 |
| NO2800866T3 (enExample) | 2018-04-14 |
| CN103687942A (zh) | 2014-03-26 |
| EP2707027A1 (en) | 2014-03-19 |
| JP2014519817A (ja) | 2014-08-21 |
| US9833504B2 (en) | 2017-12-05 |
| EP2707480A4 (en) | 2015-01-07 |
| WO2012155261A1 (en) | 2012-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272539B (en) | Compositions and methods for immunotherapy | |
| DK2925782T3 (da) | Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK2710033T3 (da) | Human immundefektvirus-neutraliserende antistoffer og fremgangsmåder til anvendelse deraf | |
| DK2663254T3 (da) | Fremgangsmåder, systemer og tilbehør, der kan anvendes til procedurer vedrørende tandimplantater | |
| HUE052485T2 (hu) | RNA készítmény immunterápiára | |
| DK3421051T3 (da) | Fremgangsmåder til glycokonjugering og sammensætninger | |
| DK2884999T4 (da) | Fremgangsmåde og sammensætninger til cellulær immunterapi | |
| DK2361704T4 (da) | Metalmultifasemateriale og fremgangsmåde til fremstilling deraf | |
| DK2707480T3 (da) | Viruslignende partikler og fremgangsmåde til fremstilling heraf | |
| DK2758349T3 (da) | Vanadiumbaserede frittematerialer og fremgangsmåder til fremstilling heraf | |
| IL227593A0 (en) | Methods and compounds for the preparation of noribogaine from wakengin | |
| IL228557A0 (en) | Solar absorbing formulations and related devices and methods | |
| CO6870003A2 (es) | Vacunas bovinas y métodos | |
| DK2908661T3 (da) | Mikroalgemelgranulater og fremgangsmåde til fremstilling deraf | |
| DK3381461T3 (da) | Peptider og fremgangsmåder til anvendelse deraf | |
| DK2896694T3 (da) | Saccharidoxidase og fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| GB201122089D0 (en) | Telecomunication apparatus and methods | |
| PL2755680T3 (pl) | Preparaty szczepionkowe w postaci cząstek | |
| LT2755678T (lt) | Pcsk9 vakcina | |
| GB201819555D0 (en) | Methods and apparatus for coring | |
| GB201119999D0 (en) | Vaccine | |
| DK2871184T3 (da) | Benzodioxolderivat og fremgangsmåde til fremstilling og anvendelse deraf | |
| DK2814508T3 (da) | Rotavirus-underenhedsvacciner og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3296317T3 (da) | Topk-peptider og vacciner, der indbefatter disse | |
| IL232145A0 (en) | Pesticide preparations and methods |